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While photoreceptor loss is the most devastating result of inherited retinal degenerations
such as retinitis pigmentosa, inner retinal neurons also undergo significant alteration.
Detailing these changes has become important as many vision restorative therapies
target the remaining neurons. In this study, the rd1-Fos-Tau-LacZ (rd1-FTL) mouse
model was used to explore inner retinal change at a late stage of retinal degeneration,
after the loss of photoreceptor nuclei. The rd1-FTL model carries a mutation in
the phosphodiesterase gene, Pde6b, and an axonally targeted transgenic beta
galactosidase reporter system under the control of the c-fos promoter. Retinae of
transgenic rd1-FTL mice and control FTL animals aged 2–12 months were processed
for indirect fluorescence immunocytochemistry. At 2 months of age, a time when the
majority of photoreceptor nuclei are lost, there was negligible c-fos reporter (FTL)
expression, however, from 4 months, reporter expression was observed to increase
within subpopulations of amacrine and ganglion cells within the central retina. These
areas of inner retinal FTL expression coincided with regions that contained aberrant
Müller cells. Specifically, these cells exhibited reduced glutamine synthetase and Kir4.1
immunolabelling, whilst showing evidence of proliferative gliosis (increased cyclinD1 and
glial fibrillary acidic protein expression). These changes were limited to distinct regions
where cone photoreceptor terminals were absent. Overall, these results highlight that
distinct areas of the rd1-FTL central retina undergo significant glial alterations after cone
photoreceptor loss. These areas coincide with up-regulation of the c-fos reporter in the
inner retina, which may represent a change in neuronal function/plasticity. The rd1-FTL
mouse is a useful model system to probe changes that occur in the inner retina at later
stages of retinal degeneration.
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Introduction
Over recent years there has been a surge of interest in vision restoring therapies that replace the
function of dead or dying photoreceptors using a variety of genetic, electronic or transplantation
methods (Busskamp et al., 2008; O’Brien et al., 2012). For any of these treatments to succeed, a
basic requirement is that the circuitry of the inner retina remains functionally intact and capable
of passing visual information to higher visual centers. Yet, over recent years, the notion that the
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inner retina remains intact following complete loss of
photoreceptors has been questioned (Jones et al., 2003; Marc
et al., 2003, 2007; Strettoi et al., 2003; Jones and Marc, 2005;
Chua et al., 2009). A range of changes occur in both neurons and
glial cells in animal models of inherited retinal degeneration, as
well as humans with retinitis pigmentosa (RP). These changes
are classiﬁed into three phases based on retinal anatomy (Jones
and Marc, 2005); Phases 1 and 2 refer to the periods of rod
photoreceptor and cone photoreceptor death, respectively, while
phase 3 is characterized by major anatomical changes in the inner
retina including re-wiring of neural processes and the formation
of a glial seal that encases the remaining retina (Marc et al.,
2003). As most vision restorative therapies will be employed after
photoreceptor death, a greater understanding of the events that
occur in phase 3 degeneration will assist in optimizing these
therapeutic approaches.
The rd1 mouse is the most widely studied mouse model
of retinal degeneration (Farber, 1995; Fletcher et al., 2011). It
carries a gene mutation in the β subunit of phosphodiesterase
6 (Pde6b), which is a similar genetic defect to patients with
autosomal recessive RP (Pittler and Baehr, 1991; McLaughlin
et al., 1993). Studies have documented both functional and
anatomical changes in this mouse model of degeneration (Strettoi
and Pignatelli, 2000; Strettoi et al., 2002; Jones et al., 2003;
Margolis et al., 2008). Apart from the obvious structural changes
in the outer retina (the loss of photoreceptors), there are also
functional changes in bipolar and ganglion cells within this early
period of degeneration (Stasheﬀ, 2008; Chua et al., 2009; Stasheﬀ
et al., 2011; Gibson et al., 2013). However, at later stages of
degeneration after photoreceptor loss, neurons of the inner retina
also show signiﬁcant anatomical alterations, including migration
of somata to ectopic sites, the establishment of aberrant synapses,
neuronal death, and glial remodeling (Jones et al., 2003; Marc
et al., 2003; Chua et al., 2013). Finally, while neurochemical
changes have been described both at early and late stages of
degeneration in the rd1 mouse, as well as in other models
of retinal degeneration (Fletcher and Kalloniatis, 1996, 1997;
Marc et al., 2003; Jones and Marc, 2005; Gibson et al., 2013),
the underlying cause and relationship between the diﬀerent
forms of inner retinal change is not clear. For that reason a
model system probing these inner retinal changes would be of
use.
The Fos-Tau-LacZ (FTL) mouse has an axonally targeted
reporter system under the regulation of the c-fos promoter
(Wilson et al., 2002). C-fos is an intermediate early gene
that is known to be up-regulated in neurons in response to
neural activity, cell death, and/or plasticity (Marti et al., 1994;
Rich et al., 1997; Wilson et al., 2002; Greferath et al., 2004,
2009). FTL mice have been useful for visualizing neural circuits
activated by a range of stimuli, including those involved in
regulating water balance (Wilson et al., 2002), learning and
memory (Ali et al., 2009, 2012) and respiratory control within
the nuclei of the brainstem (Niblock et al., 2012). When
FTL mice are bred with rd1 mice, photoreceptors display
increased c-fos reporter labeling from an early age that follows
closely the time course of photoreceptor death (Greferath
et al., 2009). However, nothing is known about c-fos reporter
(FTL) regulation at later stages of degeneration in the rd1-
FTL mouse and whether this relates to inner retinal neural
change.
In view of the increase in aberrant neural activity, plasticity
changes and possible cell death that takes place within the inner
retina at late stages of degeneration, the rd1-FTL mouse could
provide a useful tool for studying the cellular changes that occur
in the inner retina well after photoreceptor cell death. In this
study we examined the time course of c-fos reporter expression in
the rd1-FTLmouse and characterized the accompanying glial and
neuronal alterations. Our results show that c-fos reporter (FTL)
expression is upregulated in inner retinal neurons within discrete
patches in the central retina from 4 months of age. Moreover,
increased FTL expression coincides with regions displaying
considerable Müller cell change and loss of cone photoreceptor
terminals. These areas may represent regions of the retina from
which the glial seal may form. Targeting restorative therapies
distant to these retinal areas may improve outcomes.
Materials and Methods
Animals
All animal procedures were performed in accordance with
the University of Melbourne Animal Experimentation Ethics
Committee and with guidelines outlined by the National Health
and Medical Research Council and the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Rd1-FTL double-mutant mice were created by breeding rd1
homozygous mice with heterozygous FTL transgenic animals
(Wilson et al., 2002). Rd1 mice were originally obtained
from Professor Debora Farber, University of California, Los
Angeles, CA, USA and backcrossed more than 10 times with
the C57Bl6JARC obtained from the Animal Resource Centre
(Western Australia). FTL mice were originally generated at the
University of Melbourne (Parkville, Australia; Wilson et al.,
2002). The rd1-FTL mouse expresses a mutation in the β subunit
of Pde6b gene, resulting in retinal degeneration, together with an
axonally targeted transgenic marker gene (β-galactosidase) that
labels all neurons that have c-fos promoter activation (Greferath
et al., 2009). Mice examined in this study were aged from 2 to
12 months and control heterozygous FTL mice were age matched
for comparison (at least n > 7 rd1-FTL and FTL at each age
group per outcome measure). All mice used in this study were
conﬁrmed to be free of the rd8 mutation in the Crb1 gene
(Mattapallil et al., 2012).
Tissue Collection and Fixation
Mice were killed by an overdose of sodium pentobarbital (Merial
Australia, Parramatta, Australia: 120 mg/kg, intraperitoneal).
Eyes were then immediately dissected, the anterior segment
and lens discarded and the posterior eyecup ﬁxed in one of
two ways depending on the type of immunoﬂuorescence to be
performed. Posterior eye cups that were processed for indirect
immunoﬂuorescence were ﬁxed in 4% paraformaldehyde (PFA)
in 0.1 M phosphate buﬀer, pH 7.4 (phosphate buﬀered, PB)
for 30 min, washed in PB and subsequently processed through
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graded sucrose solutions (10, 20, and 30% w/v sucrose in PB).
Samples were stored at –80◦C until use.
A subset of eyes from rd1-FTL and FTL mice (n > 8 eyes)
were processed for β-galactosidase histochemistry, whereby the
mouse was transcardially perfused with 12 ml of 5% sucrose in
dH2O, followed by 12 ml of PFA with 0.005% glutaraldehyde in
PB. Eyes were immediately dissected and a hole pierced in the
eyecup at the corneal margin with a 30G needle. Eyes were then
placed in 4% PFA and the anterior eyecup and lens were removed.
The posterior eyecup was postﬁxed in 4% PFA for 10 min and
then placed in phosphate buﬀered saline (PBS). All eyes were
immediately processed for enzyme histochemistry.
β-Galactosidase Histochemistry on
Wholemount Retinae
Retinae were dissected from the posterior eyecup and placed
in the staining buﬀer (5 mM magnesium chloride, 5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, and
0.4 mg/ml 5-Bromo-4-chloro-3-indolyl-B-D-galatocpyranoside)
for 16 h under rotation at room temperature (Greferath et al.,
2004, 2009). To stop the reaction, an equivalent volume of 4%
PFA was added to the solution and the retina was washed in
PBS and mounted onto 0.5% gelatine/5% chromium potassium
sulfate-coated slides. Wholemounts were air-dried on slides and
dehydrated through graded alcohols to histolene and mounted
in Safety Mount (Fronine, Riverstone, Australia). Wholemount
retinae processed for β-galactosidase histochemistry were viewed
using a light microscope with either a 4× air objective or 40×
oil objective and tissue was imaged using an ImagePoint cooled
CCD camera (Photometrics LTD, Tucson, AZ, USA) and assessed
using Windows imaging software (Digital Optics Ltd., Auckland,
NZ). The extent of β-galactosidase expression (FTL labeling) was
quantiﬁed as a percentage of total retinal area from n ≥ 8 retinae
(mm2 FTL labeling/mm2 retinal area).
Immunofluorescence
Changes in cells in FTL and rd1-FTL mice were evaluated on
vertical sections of retina using indirect immunoﬂuorescence
as previously described (Fletcher et al., 2000; Downie et al.,
2010; Vessey and Fletcher, 2012). Brieﬂy, sections (14 μm in
thickness) were cut from OCT (Tissue Tek, Sakura Finetek,
Tokyo, Japan) embedded eyecup blocks and mounted onto
0.5% gelatine/5% chromium potassium sulfate coated slides that
were then air-dried. Slides were washed in PB and primary
antibody was applied overnight. Following incubation, sections
were again washed in PB and secondary antibody was applied
for 40 min. Table 1 contains a list of the primary and secondary
antibodies that were used. All antibodies were diluted in buﬀer
consisting of 3% normal goat serum, 1% bovine serum albumin
and 0.5% Triton X-100 in PB. Cell death was measured using
a commercially available ﬂuorometric terminal dUTP nick-end
labeling (TUNEL) kit (DeadEnd Fluoro metric TUNEL system,
Promega, Madison, WI, USA). Slides were then washed in
PB, and mounted and cover-slipped with ﬂuorescent mounting
medium (DAKO, Carpinteria, CA, USA).
Retinal sections processed for immunoﬂuorescence and
TUNEL were viewed on a confocal laser scanning microscope
(LSM 510 PASCAL, Zeiss, Oberkochen, Germany) using either a
20× air objective or a 40× oil objective and images were captured
at a resolution of 512 × 512 or 1024 × 1024 pixels using Zeiss
LSM image browser software and an appropriate ﬂuorescence
ﬁlter (Alexa TM 594/CY3: excitation 568 nm, emission ﬁlter
605/32; Alexa TM 488/FITC: excitation 488 nm, emission ﬁlter
522/32; Alexa TM 647/CY5: excitation 647 nm, emission ﬁlter
680/32). Images were collated using Adobe Photoshop CS5
(Adobe Systems, San Jose, CA, USA).
Histological Analysis
The immunolabeling of each antibody was assessed across at least
n ≥ 6 eyes, with three separate sections imaged per eye. The
co-localisation of FTL labeling with speciﬁc cell markers was
quantiﬁed and expressed as a percentage of the total number
of FTL positive cells [%, (co-label of FTL and cell marker/total
cells stained for FTL) × 100]. The markers of retinal Müller
cells were quantiﬁed in control (FTL) and rd1-FTL retinae (areas
exhibiting FTL labeling and neighboring areas lacking expression
of FTL) as cell number per mm of retina (n ≥ 6). Total and
inner retinal thickness measures were calculated from central
retinal sections (n = 6 eyes, at least three sections per eye)
that showed FTL labeling and neighboring regions that lacked
FTL expression (assessed after indirect immunoﬂuorescence,
processed with ImageJ 1.43 freeware, NIH).
Statistical Analysis
A one-way analysis of variance (ANOVA) with a Tukey’s multiple
comparison post hoc test was used to statistically compare the
change in c-fos reporter labeling across the rd1 retina. The
quantiﬁcation of glutamine synthetase (GS), Sox9, and cyclin
D1 immunolabeling was analyzed using a two-way ANOVA,
with Tukey’s multiple comparison post hoc test to evaluate the
diﬀerences. GraphPad Prism (San Diego, CA, USA) was used to
graph data and to perform the above statistical analyses.
Results
This study examined the retinal changes that take place at late
stages of degeneration (6–7 month-old animals) in the rd1-FTL
mouse model of retinal degeneration. The rd1-FTL mouse has an
axonally targeted reporter system under the control of the c-fos
promoter (Wilson et al., 2002), as well as carrying a homozygous
mutation in Pde6b. In the results described below, an increase in
the c-fos reporter is referred to as “FTL” labeling.
FTL Labeling is Increased in Inner Retinal
Neurons Well after Photoreceptor
Degeneration
Using β-galactosidase histochemistry, the time course of FTL
labeling was assessed in rd1-FTL mice up until 1 year of age and
compared to age-matched control FTL mice. In the adult (post-
natal day 135, P135) control retina (Figure 1A), FTL labeling
covered the entire retina and as described previously, was found
in a range of inner retinal neurons (Greferath et al., 2004).
By contrast, FTL labeling was virtually absent in the rd1-FTL
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TABLE 1 | List of the primary and secondary antisera used in this study.
Antiserum Dilution/Species Source/Cat. No.
β-galactosidase 1:10,000 Rabbit polyclonal MP Biomedicals; Cat#08559761
β-galactosidase 1:10,000 Chicken polyclonal Abcam; Cat#AB9361
Calretinin 1:500 Mouse monoclonal Swant; clone 6B3
CyclinD1 1:1 Rabbit polyclonal Merck Millipore; Cat#04-1151
GABA 1:500 Guinea pig polyclonal Merck Millipore; Cat#AB175
Glutamate 1:45,000 Rabbit polyclonal Gift from Dr Robert E Marc, available through Chemicon International; Cat #AB133
Glial fibrillary acid protein 1:20,000 Rabbit polyclonal DAKO; Cat# Z0334
Glycine 1:50,00 Rabbit polyclonal Gift from Prof David Pow, University of Queensland, Brisbane, QLD, Australia
GLAST (EAAT1) 1:1,000 Rabbit polyclonal Abcam; Cat# AB41751
Vesicular glutamate transporter 1 1:20,000 Guinea pig, polyclonal Merck Millipore; Cat #AB5905
Glutamine synthetase 1:1,000 Mouse monoclonal Merck Millipore; Cat# MAB302
Tyrosine hydroxylase 1:1,000 Mouse monoclonal Chemicon International; Cat #MAB318
Kir4.1 1:1,000 Rabbit polyclonal Merck Millipore; Cat#AB5818
Neuron specific nuclear protein 1:500 Mouse monoclonal Merck Millipore; Cat# MAB377
Peanut Agglutinin-Rhodamine 1:250 Fluorescent Lectin Vector Labs; Cat #RL-1072
Sox9 1:500 Rabbit polyclonal Merck Millipore; Cat# AB5535
Anti-Rabbit Alexa594 1:800 Goat polyclonal Life Technologies; Alexa Fluor R© Cat# A11037
Anti-Mouse Alexa488 1:500 Goat polyclonal Life Technologies; Alexa Fluor R©_Cat# A11001
Anti-Guinea pig Alexa594 1:500 Goat polyclonal Life Technologies; Alexa Fluor R©_Cat# A11076
Anti-Guinea pig Alexa488 1:500 Goat polyclonal Life Technologies; Alexa Fluor R© Cat# A11073
Anti-Chicken Alexa594 1:500 Goat polyclonal Life Technologies; Alexa Fluor R© Cat# A11042
Anti-Mouse Alexa647 1:500 Goat polyclonal Life Technologies; Alexa Fluor R© Cat# A21235
BisBenzimide H 0.1 mg/mL Sigma Aldrich; Cat#14530
FIGURE 1 | Fos-Tau-LacZ (FTL) reporter expression increases in the
rd1-FTL retina as a function of age. Flatmount retinae from control FTL
(A, P135), rd1-FTL (B, P105; C, P135; D, P240; E, dark adapted rd1-FTL
aged P210) mice were processed for FTL expression using β-galactosidase
histochemistry. In contrast to the wild-type retina that showed FTL labeling
throughout the retina (A), the rd1-FTL aged P105 (B) showed no FTL
labeling. However, at P135 (C) rd1-FTL retina showed distinct labeling near
the optic nerve, that subsequently expanded across the central retina (D,E).
The expression of the FTL reporter as a function of retinal area was
quantified at different ages from P105 to P365 (F). Data presented as
mean ± SEM, n ≥ 8 per group, ∗∗∗∗p < 0.0001 (one-way ANOVA). Scale
bar for (A–E) = 1 mm.
retina at a similar age (P105, Figure 1B). By P135 (Figure 1C),
there were discrete regions of FTL labeling lateral to the optic
disk in the rd1-FTL retinae. Over time, this labeling spread to
cover the central retina (Figure 1D), although the peripheral
retina never showed labeling, even after 12 months (data not
shown).
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Previous studies in young rd1-FTL animals (≤P30) have
shown that FTL labeling in the retina is inﬂuenced by light
activation (Greferath et al., 2004). In order to determine whether
this increase in FTL labeling observed at this late stage of
degeneration (≥P135) was also dependent on light activation,
7 month-old rd1-FTL animals were dark-adapted prior to
enucleation and β-galactosidase histochemistry. No diﬀerence in
the labeling pattern between the light (Figure 1D) and dark-
adapted (Figure 1E) rd1-FTL retinae was observed, indicating
this increase in FTL labeling is independent of light-induced
activation. Quantifying the extent of FTL labeling in the retina
showed an age-dependent increase in expression after 105 days
post-natal, with 29 ± 3% of the total retinal area exhibiting
FTL labeling out to 1 year of age (Figure 1F, one-way ANOVA,
p< 0.0001, n ≥ 8 per group).
The retinal cell types that were responsible for this increase
in FTL expression were evaluated using immunoﬂuorescence in
6 month-old rd1-FTL retinae. As shown in Figures 2A,C and E,
cells in the inner retina were positive for FTL labeling (anti-β-Gal,
red). In order to determine the types of cells expressing FTL
immunoreactivity, double labeling experiments were performed
with markers of amacrine cells including, GABA, glycine, and
tyrosine hydroxylase. FTL was observed to co-localize with
GABA (Figure 2B, arrows) and glycine (Figure 2D, arrows), but
not tyrosine hydroxylase (Figure 2F), suggesting that in late stage
degeneration, GABAergic and glycinergic amacrine cells express
the c-fos reporter, while dopaminergic amacrine cells do not.
This is unlike the inner retinal labeling observed in this model
during the early stages of photoreceptor degeneration (<P26)
where dopaminergic amacrine cells also express the c-fos reporter
(Greferath et al., 2009).
β-galactosidase histochemical labeling of the rd1-FTL retina
showed evidence of reporter expression within ganglion cell
axons (Figure 2G, black arrows). In order to assess ganglion
cell expression of the c-fos reporter, NeuN was used to
label all neurons in the ganglion cell layer (GCL), while
GABA immunolabeling was used to exclude displaced amacrine
cells. Triple labeling with antibodies to β-Gal, NeuN, and
GABA identiﬁed numerous ganglion cells that were labeled
for FTL (NeuN positive, GABA negative, Figure 2H, see
arrows). Quantiﬁcation of FTL positive cells in the inner
retina revealed that 28 ± 8% of FTL immunoreactive cells
were strongly GABA immunoreactive, 41 ± 20% were strongly
glycine immunoreactive, while within the GCL, 16 ± 5% were
NeuN+/GABA− neurons (n ≥ 6 animals). These data suggest
that speciﬁc subpopulations of conventional amacrine cells and
ganglion cells express the c-fos reporter during the later stages of
retinal degeneration.
FTL expression during Late-Stage
Degeneration Does Not Reflect Inner Retinal
Thinning, Nor Exclusively Correlate with
Remodeling
c-fos is known to be upregulated during cell death (Marti et al.,
1994). Indeed, our previous study of rd1-FTL mice showed
FTL labeling in photoreceptor nuclei during the period of rod
loss between post-natal day 10 and 30 (Greferath et al., 2009).
FIGURE 2 | Amacrine and ganglion cells express the FTL reporter
within the inner retina of rd1-FTL. Retinal sections of rd1-FTL mouse
(6 months of age) were labeled with anti-β-galactosidase (A,C,E; red), which
identifies FTL reporter expression (see white arrows in A,C). Retinal sections
were co-labeled with GABA (B), or glycine (D) showing FTL was co-localized
within subpopulations of GABA immunoreactive (B, white arrows) and glycine
immunoreactive (D, white arrows) amacrine cells. Retinal wholemounts were
double labeled with anti-β-galactosidase and tyrosine hydroxylase (E,F;
respectively) and no co-localization was evident. Rd1-FTL wholemount from a
4.5 month-old animal was also labeled using β-galactosidase histochemistry
showing ganglion cell axons projecting to the optic nerve express the reporter
(G, black arrows). This ganglion cell expression was confirmed in vertical
sections of rd1-FTL retina, which were triple labeled for β-galactosidase (red),
GABA (green) and NeuN (Blue). There are numerous cells in the GCL that are
co-labeled with FTL and NeuN (H, white arrows). Abbreviations: INL, inner
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer, OD, optic
disk. Scale bar for (A–F,H): 50 μm; (G): 250 μm.
In order to determine whether the amacrine and ganglion cell
labeling observed at late stages of retinal degeneration was
associated with cell death, inner nuclear layer (INL) thickness
was quantiﬁed in FTL immunolabeled regions and non-labeled
areas that were immediately adjacent. The INLs of the FTL
positive regions were not signiﬁcantly diﬀerent to the adjacent
negative regions (Figure 3A, FTL+ 30 ± 2, FTL− 31 ± 3 μm,
p > 0.05, n ≥ 6 animals), while total retinal thickness was also
unchanged (Figure 3A, FTL+ 84± 8, FTL− 84± 8μm, p> 0.05,
n ≥ 6 animals). To conﬁrm the lack of cell death involvement in
FTL labelling, TUNEL labeling was performed within the inner
retina of 4 and 6 month-old rd1-FTL mice. Limited staining was
detected, similar to that observed in age-matched FTL controls
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FIGURE 3 | Fos-Tau-LacZ reporter expression in the rd1-FTL retina is
not due to cell death nor correlated with remodeled inner retina. Total
and inner nuclear layer thickness measures were measured from vertical retinal
sections in areas exhibiting FTL expression, as well as neighboring areas
showing no FTL expression (A). Additionally, vertical sections of rd1-FTL retina
were labeled for FTL (anti-β-galactosidase, green) and DAPI (blue). Inner retinal
layer and total retinal thickness’ were similar between FTL+ sand FTL− regions
(A). Increased FTL reporter expression was observed in inner retinal regions
where the structure remained intact (B), as well as in regions where there was
evidence of anatomical remodeling (arrows, C). Furthermore, other regions that
exhibited DAPI labeled nuclei which were mislocated within the IPL, were FTL
negative (arrows, D). Data presented as mean ± SEM, n ≥ 6 per group,
p > 0.05 (two-way ANOVA). Abbreviations: INL, inner nuclear layer; IPL, inner
plexiform layer; GCL, ganglion cell layer. Scale bar: 50 μm.
(data not shown). These ﬁndings suggest that at this late stage of
retinal degeneration, the FTL labeling observed in the amacrine
and ganglion cells of the rd1-FTL retina is unlikely to be the result
of cell death.
As c-fos expression has been associated with neural plasticity,
retinal areas exhibiting anatomical remodeling were correlated
to FTL labeling. As shown in Figure 3B, FTL labeling occurred
in areas with normal inner retinal morphology, as well as in
regions with abnormally localized nuclei in the IPL, indicative of
anatomical remodeling (arrows in Figure 3C). However, other
regions that exhibited mislocalised DAPI-labeled nuclei within
the IPL, were FTL negative (arrows in Figure 3D). Thus, FTL
labeling in the inner retina did not exclusively coincide with areas
that showed evidence of remodeling, suggesting that FTL up-
regulation does not solely reﬂect neuronal plasticity changes in
the rd1-FTL retina.
FTL Labeling of Inner Retinal Neurons is
Localized to Regions of Aberrant Glia
The labeling within the rd1-FTL retina was patchy, with some
regions showing FTL in cell somata of the INL (Figure 4A
arrow, Figure 4D highlighted region), whereas neighboring areas
showed no cell soma labeling. There was, however, a relatively
consistent labeling within the GCL likely due to c-fos reporter
expression within axons (Figure 4D, also see Figure 2G). Müller
cell labeling with GS (green; Bringmann et al., 2009) also showed
a variability in staining (Figure 4B arrow, Figure 4E highlighted
region) and revealed an intriguing inverse correlation, with FTL
expression observed in retinal regions that were either devoid of,
or showed a major reduction in, GS labeling (Figures 4C,F).
Müller cells are integral to maintenance of retinal structure
and function, being involved in potassium siphoning, glutamate
and GABA turnover, chromophore recycling, energy metabolism
and maintenance of the blood retinal barrier (Bringmann et al.,
2006). To examine whether these Müller cell metabolic processes
might be compromised, rd1-FTL retinae were labeled for Kir4.1
the predominant glial inwardly rectifying potassium channel
(Kofuji et al., 2000), GLAST, the principal glutamate transporter
expressed by Müller cells (Lehre et al., 1997; Rauen et al.,
1998), and glial ﬁbrillary acidic protein (GFAP), a marker of
Müller cell gliosis. As shown in Figure 5, regions of the rd1-
FTL retina that showed reduced GS immunolabeling also showed
reduced Kir4.1 staining (Figures 5A–C). However, while GLAST-
labeling was still detected within these regions (Figures 5D–F),
it appeared abnormal when compared to neighboring GS-
expressing regions. These altered regions showed extensive GFAP
labeling (Figures 5G–I), which has been reported previously in
the rd1 mouse retina (Stasheﬀ, 2008; Chua et al., 2009; Stasheﬀ
et al., 2011; Gibson et al., 2013). These data suggest that while GS
and Kir4.1 expression is signiﬁcantly reduced, gliotic Müller cells
with the potential for glutamate uptake remained within these
aberrant regions.
These results imply that after photoreceptor degeneration
in the rd1-FTL retina, localized subpopulations of amacrine
and ganglion cells show increased FTL expression in regions
where Müller cells are dysfunctional or absent. In order to
determine if Müller cell loss occurred in these FTL-expressing
regions, retinal sections were co-labeled for GS and Sox9, a
Müller cell nuclear marker. As shown in Figure 6, Sox 9
labeling was 100% co-localized with GS positive Müller cells in
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FIGURE 4 | Fos-Tau-LacZ positive regions within the rd1-FTL retina
show Müller cell alterations. Vertical sections of the rd1-FTL mouse retina
(6 month-old) were labeled for FTL (A,D; anti-β-galactosidase, red) and
glutamine synthetase (GS; B,E; green) and areas of co-localisation assessed
(C,F). Regions that are intensely labeled for FTL correspond to regions that
show low GS labeling (white arrow; B, C). High magnification of the FTL
expressing region within the rd1-FTL retina is indicated by the white bracket and
corresponds to an area of low GS labeling. Abbreviations: INL, inner nuclear
layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar: 250 μm
(A–C), 50 μm (D–F).
FIGURE 5 | Müller cells are altered in the FTL positive regions within the
rd1-FTL retina. Vertical sections of rd1-FTL retinae (7 month-old) were labeled
for glutamine synthetise (A,D,G), Kir4.1 (B), GLAST (E), or GFAP (H), with the
double label shown in (C,F,I). Areas that showed little GS labeling (in between
arrow heads in C and F) corresponded to Müller cells that lacked Kir4.1. Despite
this, these areas still showed GLAST immunolabelling. These altered regions
were also positive for the gliosis marker GFAP. Abbreviations: INL, inner nuclear
layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar: 50 μm.
control retinae (Figure 6A), and in areas of the rd1-FTL retina
that were GS positive (Figure 6B). By contrast, FTL positive
areas that almost completely lacked GS, still showed some
cells that were Sox9 immunoreactive (Figure 6B, highlighted
region). Quantifying the number of GS and Sox9 immunoreactive
Müller cells in control FTL and rd1-FTL (FTL+ or FTL−
regions) retinae (Figure 6E), showed a signiﬁcant reduction in
immunoreactive somata between FTL positive areas and control
retinae (GS, –87 ± 2%; Sox9 –56 ± 7%; two-way ANOVA,
p < 0.0001, n ≥ 6) as well as FTL positive and negative regions
(GS, –86 ± 2%; Sox9 –53 ± 7%; two-way ANOVA, p < 0.0001,
n ≥ 6). There were no signiﬁcant diﬀerences between control
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FIGURE 6 | Müller cells in the FTL positive regions within the rd1-FTL
retina show evidence of proliferative gliosis. Vertical sections of
6 month-old control FTL (A) and rd1-FTL (B) retina were double-labeled for GS
(green) and SOX9 (red). Sox 9 immunolabeled Müller cell somata were present
in regions that showed little or no labeling for GS. Control FTL (C) and rd1-FTL
(D) were double labeled for GS (green) and Cyclin D1 (red). Cyclin D1
expression was only found in regions that showed little or no GS. GS, Sox9, and
ClyclinD1 expression was quantified in control FTL retinae, and in rd1-FTL
retinae in areas with and without FTL reporter expression (E). Data are
expressed as mean immunoreactive cells per mm retina ±SEM n ≥ 6 per group,
∗p < 0.0001 (two-way ANOVA). Abbreviations: INL, inner nuclear layer; IPL,
inner plexiform layer; GCL, ganglion cell layer. Scale bar: 50 μm.
retinae and FTL negative regions of the rd1-FTL retinae (GS, –
7 ± 6%; Sox9, –6 ± 5%: two-way ANOVA, p> 0.05, n ≥ 6).
As these FTL-positive areas exhibited several markers of
proliferative gliosis (reduced GS, and Kir4.1 expression and
increased GFAP), cyclinD1 was used to determine whether
Müller cells in these aﬀected regions had altered cell cycle
regulation. Increased cyclinD1 expression inMüller cells has been
previously reported during late stage retinal degeneration (Vessey
et al., 2014). As shown in Figure 6C, no cells in the age-matched
control retinae showed cyclinD1 expression. However, within
FTL+/GS− regions of the rd1-FTL retina, numerous Müller cells
showed cyclinD1 expression (Figure 6D, highlighted region).
When quantiﬁed (Figure 6E), a signiﬁcantly higher number of
cyclinD1 immunoreactive Müller cells were found in regions of
FTL labeling compared to control (FTL+ regions 53± 5 cells/mm
retina; control FTL 0.6 ± 0.4 cells/mm retina; two-way ANOVA,
p < 0.0001, n ≥ 6), or neighboring FTL negative regions (FTL+
regions 53 ± 5 cells/mm retina; FTL− regions 4 ± 2 cells/mm
retina; two-way ANOVA, p < 0.0001, n ≥ 6). These results
highlight that well after photoreceptor degeneration, inner retinal
FTL expression coincides with distinct regions that show reduced
Müller cell number (reduced Sox9), with the remaining cells
exhibiting aberrant expression of functional markers, including
Kir4.1, GS, and cyclin D1.
Cone Loss Occurs in Regions of Glial Loss and
Abnormality
At late stages of retinal degeneration, phase 3 remodeling is
characterized by marked anatomical changes that are thought
to be precipitated by the loss of cone photoreceptor terminals.
The association of cone-mediated remodeling on the patches of
glial abnormality and FTL expression was assessed in the rd1-FTL
(n ≥ 6 animals). Figure 7 shows representative vertical sections
taken from 6 month-old animals that were double labeled with
GS and vesicular glutamate transporter (VGLUT1) a marker for
the glutamate transporter within glutamatergic terminals (Sherry
et al., 2003). Regions that showed GS labeling (Figure 7A)
also displayed VGLUT1 labeling (Figure 7B), whereas areas
that had low levels of GS immunolabelling, corresponded to
regions that showed a complete loss of photoreceptor terminals
as indicated by an absence of VGLUT1 labeling (Figure 7C). This
ﬁnding was conﬁrmed with labeling for the cone marker, peanut
agglutinin, with normal GS regions exhibiting remnants of cone
terminals, whereas GS depleted regions showed no labeling of
synaptic terminals (data not shown). Overall, the results of this
study highlight that during late stage retinal degeneration there
are localized changes in inner retinal neurons (amacrine and
ganglion cells) that are coincident with aberrant Müller cells and
that these regions correspond to regions where cone terminals are
lost.
Discussion
c-fos is an intermediate early gene that is known to be
regulated during cell death, altered neural function and neural
plasticity. From approximately 4 months of age, a time where
most photoreceptor nuclei have been lost, c-fos reporter (FTL)
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FIGURE 7 | Cone photoreceptor loss is evident in areas containing
aberrant Müller cells. Vertical sections of 6 month-old rd1-FTL retinae were
double labeled for VGLUT1 (red) and GS (green) in order to investigate the
presence of cone photoreceptor terminals in FTL-rich regions. VGLUT1
immunolabeling is expressed in the OPL and IPL (A). High magnification of
the OPL shows that in regions where GS is expressed, cone photoreceptor
terminals remain (B), however, in areas of low to no GS (C), VGLUT
expression is absent. Abbreviations: OPL, outer plexiform layer; INL, inner
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar:
50 μm.
expression was increased in subsets of amacrine and ganglion
cells across the central rd1-FTL retina. These regions of FTL
expression were not correlated with cell death or inner retinal
remodeling. These areas did correspond to discrete regions
of abnormal Müller cells which showed reduced GS, Kir4.1,
and Sox9 immunolabelling, in addition to aberrant cell cycle
regulation. Furthermore, these aberrant Müller cells were present
in regions that showed a complete loss of cone photoreceptor
terminals. These results highlight that inner retinal changes occur
in the rd1-FTL retina in a localized fashion and are associated
with the loss of cone photoreceptor terminals and Müller cell
anomalies.
FTL Expression as a Marker of Inner Retinal
Change
The results of this study show that c-fos reporter (FTL) expression
changes in the rd1-FTL with age. Consistent with our previous
ﬁndings (Greferath et al., 2009), retinal FTL expression was low
at 3 months of age in the rd1-FTL compared to control FTL
mice, most likely reﬂecting the lack of neural activity at this
age. This is supported by previous work that indicates virtually
all photoreceptor nuclei are lost in the central rd1 retina by
2 months of age (Jimenez et al., 1996). While FTL expression
was initially low, it re-emerged within subpopulations of both
amacrine and ganglion cells by 4 months of age (from P120).
This increase in expression was not due to light-induced neuronal
activation as we have previously reported in young (>P30) rd1-
FTL animals (Greferath et al., 2004). Over the next 8 months
(P120–P365) FTL expression increased within the central retina,
yet never extended out into the peripheral retina. It must be
highlighted that the oldest animals used in this study were 1 year
of age and so peripheral FTL expression after this time cannot
be discounted. The reason for this central localisation of c-fos
reporter expression is unclear, however, a central to peripheral
gradient in retinal degeneration has been reported in both the rd1
and rd1-FTL retinae (Carter-Dawson et al., 1978; Greferath et al.,
2009).
The FTL transgene was used as a reporter for c-fos, an early
intermediate gene that is known to be upregulated during cell
death, neural function and neural plasticity. The increase in FTL
expression in the amacrine and ganglion cells from 4 months
of age was not associated with an increase in inner retinal cell
death, as our results showed no diﬀerence in thickness of the
INL, in either FTL-immunolabeled regions or neighboring FTL-
negative regions. There was also no appreciable level of TUNEL
labeling and certainly no speciﬁc localisation to FTL+ regions.
Furthermore, the data did not support a role for c-fos reporter
expression as a biomarker of inner retinal remodeling since
anatomical remodeling was observed in FTL+ regions, as well
as FTL− regions. With previous work on the rd1 mouse model
showing evidence of altered inner retinal neurochemistry, as well
as aberrant amacrine and ganglion cell function (Stasheﬀ, 2008;
Chua et al., 2009; Choi et al., 2014), it is possible that these
functional alterations are related to the observed FTL expression.
Our data showed that anomalies in glial cells, speciﬁcally
Müller cells, coincide with the localized regions of FTL up-
regulation. Based on the Sox9 labeling, Müller cells were reduced
in number within FTL+ regions of retina. In addition, the Müller
cells that remained in these regions were gliotic and showed
reduced glutamate synthetase and Kir4.1 immunolabelling. In
view of the importance of both glutamate turnover and potassium
siphoning in maintenance of neuronal function (Bringmann
et al., 2006), we propose that theMüller cell dysfunction observed
in localized regions could play a role in the up-regulation of FTL
expression within the inner retinal amacrine and ganglion cells.
In support of this, Müller cells are known to directly modulate
ganglion and amacrine cell function (Newman and Zahs, 1998;
Miller, 2004). In addition, these aberrant Müller cells within
the FTL expressing regions may be sites of future glial scar/seal
formation which is known to occur in phase 2/3 remodeling
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(Marc et al., 2003). Previous work has indicated that, at time
periods equivalent to the initiation of FTL expression (>P101),
Müller cells exhibit distinct remodeling events, which contribute
to the glial seal (Chua et al., 2013). Obviously further work will be
required to determine whether these aberrant Müller cells modify
the activity of their surrounding amacrine/ganglion cells, and
serve as sites for future glial seals.
The Role of Cone Photoreceptors in FTL
Up-Regulation
While the majority of cone photoreceptors are lost by P90 – 100
in the rd1 mouse retina, cone remnants, including the presence
of synaptic ribbons can remain for extended periods (Carter-
Dawson et al., 1978). Our data showed that areas exhibiting
dysfunctional Müller cells corresponded to regions without cone
photoreceptor terminals. These data could reﬂect the importance
of residual cone terminals in glial cell function, with the ultimate
loss of these terminals resulting in glial dysfunction and/or FTL
up-regulation within the inner retina. This idea is supported
by work showing that cone loss occurs in patches (Jones et al.,
2003), similar to the pattern of observed glial changes in the
current study. Furthermore, previous work has shown that the
preservation of cones can preserve the inner neural retina from
signiﬁcantly remodeling (Marc et al., 2003, 2007; Jones et al.,
2012).
Significance of Findings for Photoreceptor
Restorative Therapies
Many studies of the rd1 mouse retina have shown that there are
structural and functional changes in inner retinal cells following
photoreceptor loss (Strettoi and Pignatelli, 2000; Strettoi et al.,
2002; Marc et al., 2007; Margolis et al., 2008; Sekirnjak et al.,
2011). Bipolar and horizontal cells change morphology and
retract their dendrites (Strettoi and Pignatelli, 2000; Strettoi
et al., 2002) as well as sprouting thin processes from their
somata (Strettoi and Pignatelli, 2000). Ganglion cells have shown
changes in their oscillatory activity (Margolis et al., 2008; Stasheﬀ,
2008; Stasheﬀ et al., 2011) and ion permeability (Marc et al.,
2007; Chua et al., 2009). A caveat of many of these studies is
that while they use animals at a stage when the majority of
photoreceptors have died, they are in the early stages of the
remodeling process (generally <P100). Evidence from this study
suggests that the FTL model may provide an early biomarker for
glial scar formation and the loss of remnant cones at later stages
in the retinal degeneration process, thus allowing these processes
to be explored. In particular, it may be useful in identifying
and targeting retinal regions that are more amenable to the
implantation of vision restorative therapies.
In summary, the results of this study highlight that the rd1-
FTL mouse may be a useful and unique tool for analysing retinal
integrity during late stages of retinal degeneration. The strong
up-regulation of c-fos reporter (FTL) that occurred well after
photoreceptor loss and remained in the central retina throughout
later stages of retinal degeneration, were independent of cell
death, structural remodeling and any residual light response.
Rather, it was associated with areas of dysfunctional glial cells and
complete cone photoreceptor loss. Inhibiting these glial changes
or preserving cone photoreceptors may assist with maintaining
inner retinal integrity.
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